Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Aimmune Therap Cmn (AIMT)

19.68 +0.52 (+2.71%)

6/22/2017  12:16pm

Open:

19.23

Pre. Close:

19.16

High:

19.75

Low:

19.10

Volume:

68,020

Market Cap:

990.73M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.47 - 19.85

19.85 - 20.1

Low:

17.94 - 18.04

18.04 - 18.11

Close:

18.89 - 19.3

19.3 - 19.56

Technical analysis  (as of: 2017-06-21 4:29:42 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 22.94     One year: 26.79

Support:

Support1: 17.37    Support2: 15.97

Resistance:

Resistance1: 19.64    Resistance2: 22.94

Pivot:

17.66

Moving Averages:

MA(5): 17.97     MA(20): 17.71

MA(100): 19.66     MA(250): 18.10

MACD:

MACD(12,26): -0.18     Signal(12,26,9): -0.40

%K %D:

%K(14,3): 77.12     %D(3): 57.06

RSI:

RSI(14): 57.01

52-Week:

High: 27.31  Low: 9.77  Change(%): 54.0

Average Vol(K):

3-Month: 319  10-Days 352

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AIMT has closed above the upper band by 1.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 5.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 22 Jun 2017 15:33:45 GMT
Stock Volatility Risk Alert: Aimmune Therapeutics Inc Stock Volatility Hits An ...

Tue, 20 Jun 2017 10:30:00 GMT
Aimmune Therapeutics Presents European Phase 3 PALISADE Screening Data at 2017 ...

Wed, 11 Jan 2017 14:30:08 GMT
2017: A Transformational Year For Aimmune Therapeutics

Thu, 22 Jun 2017 11:48:45 GMT
Aimmune Therapeutics, Inc. (NasdaqGS:AIMT): What's Inside the Numbers

Wed, 07 Jun 2017 12:30:06 GMT
Food allergy treatment company Aimmune Therapeutics opening Clearwater ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

50.34

Shares Float (M)

26.74

% Held by Insiders

23.89

% Held by Institutions

3.00

Shares Short (K)

4200

Shares Short Prior Month (K)

4500

Stock Financials

EPS

-2.030

EPS Est. Current Year

-2.660

EPS Est. Next Year

-3.270

EPS Est. Next Quarter

-0.710

Forward EPS

-3.273

Book Value (p.s.)

5.260

PEG Ratio

0.15

Profit Margin

Operating Margin

Return on Assets (ttm)

-24.2

Return on Equity (ttm)

-39.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.820

Qtrly Earnings Growth

Operating Cash Flow (M)

-68.14

Levered Free Cash Flow (M)

-43.57

FoxReading.com

Valuation

P/E

-9.44

P/E Growth Ratio

0.03

P/BV

3.64

P/S

P/CF

-14.15

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.